Ref: IMD-7-2236

Case study

Reference: IMD-7-2236

Order this case study

From HealthKartPlus to 1mg: Growth Plans - IMD Case Study

James E. Henderson

By Professor James E. HendersonJames E. Henderson, Matthias Abicht, Pavlos Batagiannis, Bryan Frey and Peter Ulwahn

The “1mg” case focuses on a key strategic dilemma of an entrepreneur in times of digitalization. Should 1mg be just an e-pharmacy and designed as pure pipeline business, a marketplace or be a hybrid between these two? Should it adhere to the current stakeholder constellation, or should the needs of patients, and no longer those of doctors and hospitals, be at the centre of the healthcare ecosystem? India’s healthcare market in 2014 was expected to grow with 14% CAGR reaching by 158B$. E-pharmacies not only enjoyed the support of the national government to reduce costs and improve quality of medication, but also to increase access to people in rural areas, comply with India regulation and increase sales tax collection. Traditional pharmacies were regulated under the Drug & Cosmetics Act whereas e-pharmacies were regulated under the IT Act. These different regulatory bases created distortion. It was expected that regulation would be clarified and give digitalization a strong boost. That said, the traditional brick and mortar pharmacies were still playing a critical role in the overall supply chain. At the same time a plethora of competitors were attracting funds by international venture capitalists and gain market traction, either based purely on new digital technologies or on their existing healthcare footprint. The case describes the different market segments based on demographics, health habits, age, and combines it with the penetration data of the mobile industry in the life of urban & rural Indians. The case also tackles the question of profitability versus growth and provides all the elements needed for a debate over the business model choice to be implemented.

Learning Objective

  • Understand the characteristics but also the limitations of the platforms
  • How the ecosystem can be changed by altering the focal point of the stakeholders mapping (doctors to patients)
  • How to apply different business models in an industry (Platforms, E-commerce, or Hybrid) and how regulations, or their lack, impact the chance of success
  • Understand the impact of the growth and profitability metrics in a platform / hybrid business model.
Keywords Blue Ocean Strategy, Business Model, Customer Insight, Five Forces Framework, Platform Strategy, Segmentation, Strategy
Settings Asia, India
Tata 1mg, Tata Group
Type Field Research
Copyright ©2021
Language English
Related material Video
Order this case study

Reference: IMD-7-2236

IMD case studies are distributed through case clearing houses. In order to browse the collection and purchase copies please visit the links below.

The Case Centre, UK Office

Cranfield University

Wharley End Beds MK43 0JR, UK
Tel +44 (0)1234 750903
Fax +44 (0)1234 751125
Email [email protected]

The Case Centre, US office

Babson College

Babson Park, Wellesley MA 02457, USA
Tel +1 781 239 5884
Fax +1 781 239 5885
Email [email protected]

Harvard Business School Publishing

60 Harvard Way, Boston MA 02163, USA
Tel (800) 545-7685 Tel (617)-783-7600
Fax (617) 783-7666
Email [email protected]

Asia Pacific Case Center

NUCB Business School

1-3-1 Nishiki Naka
Nagoya Aichi, Japan 460-0003
Tel +81 52 20 38 111
Email [email protected]

Copyright information

IMD retains all proprietary interests in its case studies and notes. Without prior written permission, IMD cases and notes may not be reproduced, used, translated, included in books or other publications, distributed in any form or by any means, stored in a database or in other retrieval systems. For additional copyright information related to case studies, please contact Case Services.


Research Information & Knowledge Hub for additional information on IMD publications

Case study

Reference: IMD-7-2236

Order this case study
Looking for something specific?

Keep reading